Market Outlook

By 2035, the U.S. Autonomous Surgical Robotics Market is expected to reach approximately USD 15.51 billion, expanding at a CAGR of 18.50% during the forecast period 2026–2035. The market is estimated at USD 2.84 billion in 2025, compared with approximately USD 1.44 billion in 2021, USD 1.71 billion in 2022, USD 2.02 billion in 2023, and USD 2.40 billion in 2024. Historical analysis covers 2021–2024, 2025 is the base year, and all market values in this report are expressed in USD billions.

For the purpose of this report, autonomous surgical robotics does not imply unsupervised surgery without a physician. The commercially relevant U.S. market currently consists primarily of robotic platforms that move beyond basic surgeon teleoperation through intelligent planning, automated alignment, computer-vision guidance, anatomical recognition, constrained robotic execution, automated safety functions, adaptive navigation, and task-level autonomy while a qualified clinician maintains supervisory authority. Fully autonomous soft-tissue surgery remains predominantly investigational.

This distinction is strategically important. The United States already has one of the world’s deepest robotic-assisted surgery infrastructures, creating a large installed base from which increasingly autonomous functionality can be commercialized. More than 3.1 million da Vinci procedures were performed globally during 2025, while U.S. procedure growth remained in the mid-teens. At the same time, orthopedic robotics is moving from navigation and surgeon-controlled assistance toward automated planning and autonomous bone preparation. In 2025, an FDA-cleared semi-autonomous total knee platform entered the strategic portfolios of a major orthopedic manufacturer, while a surgeon-supervised fully autonomous version progressed through clinical investigation.

Market expansion will therefore be driven less by hospitals abruptly replacing surgeons with robots and more by progressive automation of individual surgical tasks. Automated anatomical registration, incision planning, implant positioning, tissue tracking, camera control, instrument safety monitoring, suturing assistance, ablation trajectory execution, bone cutting, and intraoperative decision support will represent increasingly monetizable layers of surgical robotics.

The investment thesis is reinforced by U.S. hospital scale. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and nearly 35.7 million annual hospital admissions. Medicare payment policies also affect approximately 6,100 ambulatory surgery centers, creating a large potential outpatient market for compact, workflow-efficient robotic technologies. Autonomous capabilities that reduce operating-room variability, simplify training, improve reproducibility, decrease setup burden, and allow high-value robotic procedures to migrate into lower-cost sites of care will command increasing attention from procurement committees.

The central competitive shift through 2035 will be from robotic hardware competition to intelligent surgical platform competition. Future winners will combine robotics, imaging, computer vision, artificial intelligence, surgical data, workflow analytics, connectivity, and clinically validated automation within a controlled regulatory framework.

 

Introduction

According to the U.S. Autonomous Surgical Robotics Market Report, surgical robotics is entering a structural transition from mechanical assistance toward progressively intelligent execution. First-generation systems primarily translated the surgeon’s hand movements into precise robotic instrument movements. Emerging systems increasingly interpret imaging, establish virtual boundaries, develop procedure plans, identify anatomy, monitor instrument position, automate repetitive actions, and adjust robotic behavior within predefined clinical constraints.

This evolution creates a market that cuts across traditional medtech categories. Autonomous surgical robotics includes soft-tissue robotic surgery, orthopedic robotics, spine and neurosurgical platforms, image-guided interventional robots, endoluminal systems, robotic microsurgery, and selected therapeutic platforms in which algorithms increasingly perform defined procedural functions.

The U.S. is particularly well positioned for adoption because it combines a mature surgical infrastructure with strong capital availability, advanced academic hospitals, established robotic surgery programs, large procedure volumes, extensive digital operating-room infrastructure, and a regulatory environment capable of evaluating both hardware and software-based medical devices. The country also provides manufacturers access to sophisticated surgeons capable of conducting pivotal clinical trials and generating real-world evidence.

Demand is further supported by the scale of procedures potentially addressable by robotic automation. U.S. inpatient hospital care historically accounts for millions of operating-room procedures annually. Orthopedic registries alone now contain information from more than 4.4 million hip and knee arthroplasty procedures collected between 2012 and 2024, demonstrating both the scale of the procedural opportunity and the increasingly data-rich environment available for algorithm development and benchmarking.

The economic argument is becoming equally important. Autonomous functions are attractive when they can reduce variability rather than merely increase technical sophistication. Hospital administrators increasingly evaluate whether robotics can improve operating-room utilization, reduce surgeon learning curves, standardize procedural steps across locations, decrease revision risk, enable less experienced facilities to perform complex procedures safely, or move appropriate cases toward outpatient settings.

Labor economics also strengthen the case for automation. The U.S. could face a shortage of approximately 10,100 to 19,900 surgeons by 2036. Autonomous robotics will not eliminate the need for surgeons, but intelligent assistance can potentially increase the productivity of scarce clinical expertise by automating standardized portions of procedures, improving preparation, simplifying navigation, and increasing consistency.

Clinical demand is simultaneously becoming more complex. Approximately 40.3% of U.S. adults have obesity, while the population continues to age and chronic diseases requiring surgical intervention remain prevalent. The U.S. population aged 65 and above represented approximately 18.9% of the population in 2025. These trends increase procedure volumes while making many patients more clinically complex, strengthening demand for technologies capable of improving precision and reproducibility.

The long-term market opportunity is therefore not based on replacing physician judgment. It is based on systematically transferring predictable, measurable, repeatable surgical steps to intelligent technology while keeping clinical accountability within the surgical team.

 

Key Market Drivers: What’s Fueling the U.S. Autonomous Surgical Robotics Market Boom?

The first major driver is the rapid expansion of robotic-assisted surgery itself. Robotic platforms are already embedded in major U.S. urology, gynecology, general surgery, thoracic, orthopedic, and specialty programs. This installed infrastructure gives autonomy developers something that earlier generations of medical robotics did not have: an existing clinical workflow into which new software and automated functionality can be introduced. Hospitals do not necessarily need to adopt fully autonomous systems immediately. Increasing autonomy can arrive through software upgrades, next-generation instruments, AI modules, automated planning, and new robotic platforms.

The second driver is pressure to reduce variability in surgical performance. Experienced surgeons frequently achieve excellent outcomes, but healthcare systems operate across hundreds of physicians, multiple campuses, different staffing models, and highly variable procedure volumes. An intelligent robotic platform can convert elements of expert surgical technique into reproducible workflows. Automated implant planning, virtual boundaries, anatomical landmark detection, instrument tracking, and trajectory control can improve consistency across operators while preserving surgeon oversight.

The third driver is U.S. surgical workforce pressure. A projected shortage of up to nearly 20,000 surgeons by 2036 creates a strong productivity incentive. Autonomous surgical robotics is unlikely to substitute for surgeon capacity on a one-to-one basis, but it can improve the leverage of highly trained clinicians. A system that reduces setup decisions, automates repetitive movements, provides intraoperative guidance, or executes a predefined task under supervision can enable surgeons to focus more attention on complex judgment.

The fourth driver is the migration of suitable surgical procedures to ambulatory settings. Medicare policies influence approximately 6,100 ASCs, and hospital systems are increasingly building or acquiring outpatient surgery capacity. Conventional robotic systems have historically been difficult for smaller facilities because of capital requirements, footprint, infrastructure, instrument expense, and utilization thresholds. Smaller modular platforms, mobile systems, miniaturized robots, and automation that simplifies workflow can improve robotic economics in ASCs.

The fifth driver is orthopedic surgery’s movement toward automated execution. Orthopedics provides an especially favorable environment for autonomy because bone is rigid, anatomical structures can be imaged accurately, operative plans can be mathematically defined, and robotic cutting can be constrained within predetermined boundaries. Automated implant planning and semi-autonomous bone preparation therefore face fewer technical variables than fully autonomous manipulation of deformable soft tissue. This makes knee and other orthopedic procedures an important commercialization pathway for higher levels of autonomy.

The sixth driver is the rise of surgical computer vision. Modern robotic platforms generate substantial amounts of high-resolution procedure data. Computer vision can identify instruments, understand operative phases, detect anatomical structures, monitor instrument location, and eventually support prediction of surgical events. As surgical video datasets grow, manufacturers can train algorithms capable of transforming robotic platforms from passive tools into context-aware systems.

The seventh driver is hospital demand for measurable return on capital. Robotic purchasing committees increasingly analyze procedure contribution margin, instrument cost, OR utilization, procedure conversion from open to minimally invasive surgery, surgeon recruitment, patient demand, service-line differentiation, and length of stay. Autonomous functions will gain adoption when they generate economic outcomes such as faster planning, fewer workflow interruptions, lower variability, shorter procedure time, or expanded robotic capacity.

The eighth driver is competitive disruption. Intuitive Surgical’s historic scale created an established standard for robotic soft-tissue surgery, but the U.S. market is becoming materially more competitive. Medtronic, Johnson & Johnson MedTech, CMR Surgical, Distalmotion, Virtual Incision, and other developers are creating alternative platform architectures. Competition increases the likelihood that automation, AI, workflow intelligence, and digital services will become major points of differentiation rather than optional features.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. Autonomous Surgical Robotics Market is moving toward what can be described as closed-loop surgical intelligence. Traditional robotics primarily executed commands generated continuously by the surgeon. Emerging systems increasingly observe the operative environment, interpret information, propose or select actions, execute predefined tasks, verify the outcome, and return control or request intervention when predefined conditions are exceeded.

Computer vision is one of the most strategically important enabling technologies. Real-time algorithms can track instruments, monitor the visible surgical field, recognize structures, identify deviations from planned workflows, and generate safety notifications. In 2026, FDA-cleared real-time AI functionality was introduced for a major soft-tissue robotic platform to visually notify surgical teams when selected instruments move beyond the visible field. While comparatively simple relative to full autonomy, this represents an important commercialization step toward context-aware robotic surgery.

Orthopedic robotics is advancing even further. Automated planning algorithms can establish implant positioning using patient anatomy and surgeon preferences, while robotic systems can maintain cutting planes or execute bone preparation inside predefined safety boundaries. The acquisition of an AI-driven orthopedic robotics developer by a major orthopedic company demonstrates that fully autonomous or near-autonomous bone preparation has moved from a research concept into a strategic industry development program.

AI-based preoperative and intraoperative planning is another growth area. Future surgical robots will increasingly combine CT, MRI, ultrasound, fluoroscopy, endoscopy, and real-time sensor data to generate patient-specific procedure plans. Rather than forcing physicians to interact with separate planning systems, planning is expected to become a native layer of the robotic platform.

Digital surgical twins could eventually allow systems to simulate procedure steps before execution. Patient anatomy, implant geometry, surgeon preferences, tissue behavior, and historical outcomes could be combined to evaluate alternative approaches. This capability will be particularly valuable in orthopedic reconstruction, neurosurgery, spine surgery, tumor ablation, and other procedures in which trajectory and geometry strongly influence outcomes.

Automated suturing remains an important long-term objective in soft-tissue autonomy. Research platforms have demonstrated autonomous intestinal anastomosis in preclinical models, illustrating the possibility of autonomous manipulation of deformable tissue. Commercial translation is considerably more difficult because soft tissue changes shape, bleeds, stretches, shifts position, and reacts differently across patients. As a result, supervised autonomy and narrow task automation will remain more commercially relevant than unrestricted autonomous soft-tissue surgery for much of the forecast period.

Manufacturers are also developing smaller robotic platforms. Miniaturized and modular robots lower the infrastructure threshold required to adopt robotic surgery and can improve utilization by moving between operating rooms. Compact systems are particularly relevant to ASCs and community hospitals, where a large fixed robotic installation may not have sufficient utilization to justify its capital cost.

The ultimate innovation benchmark will not be the percentage of a procedure a robot can technically perform independently. Commercial success will depend on whether automation is predictable, clinically validated, easy to override, economically valuable, compatible with existing workflows, and trusted by surgeons.

 

Segmentation Insights

The U.S. Autonomous Surgical Robotics Market is segmented on the basis of system type, level of autonomy, application, end user, and region.

 

By System Type

Soft-Tissue Robotic Surgical Platforms

Soft-tissue platforms represented an estimated USD 0.91 billion in autonomy-attributable U.S. market value in 2025, making them the largest system category. These systems are used across general surgery, urology, gynecology, thoracic surgery, and selected gastrointestinal procedures.

The principal growth opportunity is the addition of intelligent functions to an already established robotic workflow. Computer vision, automated camera management, instrument tracking, anatomical recognition, digital procedure planning, and safety monitoring can be introduced incrementally without requiring hospitals to accept unrestricted autonomous operation.

New U.S. regulatory authorizations are also increasing platform competition. Medtronic’s Hugo system entered U.S. commercial practice following FDA clearance for urologic procedures, while Johnson & Johnson’s OTTAVA platform received U.S. De Novo authorization in 2026 for multiple upper-abdominal general surgery procedures. CMR Surgical and Distalmotion are also expanding U.S. indications.

Orthopedic Robotic Systems

Orthopedic surgical robotics accounted for approximately USD 0.74 billion in 2025 and represents the most commercially mature pathway toward higher autonomy. Knee and hip replacement procedures can be planned from patient-specific anatomy, and robotic systems can constrain or execute bone preparation with high geometric precision.

The segment is moving from navigation toward intelligent planning, semi-autonomous execution, and eventually surgeon-supervised autonomous bone preparation. Zimmer Biomet’s acquisition of Monogram Technologies materially strengthened this transition. The acquired CT-based semi-autonomous total knee technology received FDA clearance in 2025, while a fully autonomous version entered clinical investigation.

Robotic adoption within joint replacement is still far from universal, leaving substantial runway. National orthopedic registry data show robotic assistance in primary total hip arthroplasty remains in the single-digit percentage range, illustrating how much procedure penetration remains available.

Spine and Neurosurgical Robotic Systems

Spine and neurosurgical robotics represented an estimated USD 0.43 billion in 2025. These procedures are well suited to algorithmic planning and robotic trajectory guidance because millimeter-scale accuracy is essential and anatomical targets can often be defined through imaging.

The strongest opportunity lies in automated trajectory planning, screw placement guidance, stereotactic procedures, cranial navigation, and integration of robotics with intraoperative imaging. The market is expected to evolve toward platforms capable of automatically registering anatomy, optimizing trajectories, positioning instruments, and verifying execution.

Globus Medical, Brainlab, Renishaw, and other specialized navigation and robotics companies are important participants in this ecosystem.

Endoluminal and Interventional Robotic Systems

Endoluminal and image-guided interventional robotics represented approximately USD 0.48 billion in 2025. The category includes robotic bronchoscopy, robotic tumor ablation, waterjet tissue resection, and related image-guided therapeutic platforms.

PROCEPT BioRobotics is particularly relevant because robotic Aquablation combines imaging, treatment planning, and robotically controlled tissue resection. Noah Medical and other robotic bronchoscopy developers demonstrate how navigation, imaging, and procedural automation can converge.

Interventional robotics is strategically attractive because procedures may rely on defined targets and trajectories rather than continuous manipulation of complex soft tissue.

Microsurgery and Specialty Robotic Systems

Microsurgery and specialty systems represented approximately USD 0.28 billion in 2025. These platforms address clinical environments where human physiological limitations such as tremor, motion scaling, and physical access become constraints.

Robotic microsurgery is gaining U.S. clinical credibility following FDA authorization of specialized systems capable of manipulating exceptionally small vessels and tissues. Over time, automation could support motion stabilization, automated trajectory correction, suture placement assistance, and procedure standardization.

 

By Level of Autonomy

Intelligent Assistance and Low-Level Autonomy

Intelligent assistance represented approximately 63% of the 2025 market. This category includes systems that automate planning, alignment, camera control, tracking, virtual boundaries, safety alerts, or other functions while the surgeon remains the continuous procedural decision-maker.

This will remain the largest segment through the near term because it provides measurable workflow advantages without creating the regulatory, liability, and physician-trust challenges associated with higher autonomy.

Task-Level and Conditional Autonomy

Task-level and conditional autonomy accounted for approximately 29% of 2025 market value. Systems in this category can execute predefined components of surgery once the surgeon has approved the plan and established operating parameters.

Orthopedic bone preparation, robotically controlled tissue resection, trajectory execution, and selected image-guided interventions are among the strongest applications. This category is expected to gain substantial share through 2035.

Supervised High Autonomy

Supervised high-autonomy systems represented approximately 7% of 2025 market value, largely through advanced robotic execution capabilities and development-stage technology attribution. The surgeon remains immediately available to supervise, approve, interrupt, or modify robot behavior.

This segment is expected to record the strongest percentage growth because orthopedic and image-guided procedures are moving progressively closer to autonomous execution.

Fully Autonomous Surgery

Fully autonomous systems represented less than 1% of commercially attributable 2025 value and remain primarily a research and clinical-development category. Commercial adoption will require substantial advances in perception, tissue modeling, emergency handling, validation methodology, human factors, cybersecurity, liability frameworks, and regulatory science.

 

By Application

Orthopedic Surgery

Orthopedic surgery was the largest application segment, representing approximately USD 0.76 billion in 2025. Knee arthroplasty remains the principal commercial opportunity, followed by hip replacement and expanding opportunities in other musculoskeletal procedures.

Automation can improve implant positioning, alignment consistency, bone preparation accuracy, and procedure reproducibility. Because the surgeon can predefine a geometrically precise operative plan, orthopedics is expected to remain the leading application for higher autonomy through the early forecast period.

General Surgery

General surgery represented approximately USD 0.69 billion in 2025. Hernia repair, cholecystectomy, colorectal surgery, bariatric surgery, and other abdominal procedures provide a large addressable base.

The emergence of alternative soft-tissue robotic platforms is strategically important because it should accelerate competition around operating-room footprint, instrument economics, procedure time, open-console architecture, AI integration, and outpatient suitability.

Urology

Urology accounted for approximately USD 0.48 billion in 2025 and remains one of the most established robotic surgical specialties. Prostatectomy and other urological procedures created much of the original U.S. clinical foundation for robotic-assisted surgery.

The next growth phase will increasingly involve workflow automation, image integration, advanced energy, intelligent safety systems, and robotic tissue treatment rather than robotic manipulation alone.

Gynecologic Surgery

Gynecology represented approximately USD 0.34 billion in 2025. Hysterectomy, endometriosis procedures, sacrocolpopexy, salpingo-oophorectomy, and related surgeries are increasingly targeted by new robotic platforms, particularly systems designed for outpatient environments.

Gynecology is commercially important because procedure volumes are substantial and many surgeries can migrate to ASCs when patient selection and reimbursement permit.

Neurosurgery and Spine

Neurosurgery and spine accounted for approximately USD 0.31 billion in 2025. Robotic trajectory guidance, imaging integration, navigation, and automated planning offer compelling value because procedural accuracy is critical and error tolerance is low.

The convergence of intraoperative imaging, navigation, AI, and robotics should increase the degree of automation available to surgeons over the next decade.

Other Applications

Other applications represented approximately USD 0.26 billion in 2025 and include thoracic surgery, microsurgery, interventional oncology, robotic bronchoscopy, specialty ENT applications, and other emerging procedure categories.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated health systems accounted for approximately USD 1.67 billion, or nearly 59% of the market in 2025. They remain the principal purchasers of capital-intensive robotic systems because they perform the highest volumes of complex surgery and have the infrastructure required for multidisciplinary robotic programs.

Large health systems increasingly negotiate enterprise arrangements that combine systems, instruments, service contracts, training, software, analytics, and utilization commitments. Autonomous capabilities will therefore need to demonstrate economic value across an installed robotic fleet rather than only at an individual surgeon level.

Academic and Teaching Medical Centers

Academic and teaching centers represented approximately USD 0.49 billion in 2025. Their market influence is disproportionately large because they conduct clinical trials, evaluate emerging technologies, train surgeons, develop procedural protocols, and generate evidence used by community hospitals.

Higher-autonomy technologies are likely to enter these institutions before broad community deployment.

Ambulatory Surgery Centers

ASCs represented approximately USD 0.41 billion in 2025 and are expected to be among the fastest-growing end-user groups. Compact footprint, predictable procedure economics, rapid room turnover, minimal staffing requirements, and low per-procedure cost are especially important.

Autonomous functions could become more valuable in ASCs than in major academic centers because automation can reduce operational complexity and support standardized workflows.

Specialty Surgical Centers

Specialty surgical hospitals and physician-led surgical facilities represented approximately USD 0.20 billion in 2025. Orthopedic specialty facilities are particularly relevant due to high procedure standardization and strong interest in technology-enabled joint replacement.

Federal, Veterans and Other Public Healthcare Facilities

Federal and other public systems represented approximately USD 0.07 billion in 2025. Adoption is comparatively selective but can become important for clinical validation, training, and expansion of advanced surgical technologies to geographically distributed populations.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Autonomous Surgical Robotics Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population size, hospital density, concentration of robotic surgical programs, academic research capacity, orthopedic procedure volumes, surgeon availability, payer mix, ASC penetration, medtech investment, and availability of capital for operating-room modernization.

The South represented approximately USD 0.93 billion in 2025, followed by the West at USD 0.78 billion, Northeast at USD 0.65 billion, and Midwest at USD 0.48 billion. The South is expected to remain the largest regional market, while the West is projected to record the fastest expansion.

South

The South represented approximately USD 0.93 billion in 2025 and is projected to approach USD 4.91 billion by 2035, corresponding to an estimated CAGR of approximately 18.1%.

The region includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia.

Texas and Florida are the two most strategically important Southern markets. Texas combines large metropolitan populations with sophisticated surgical ecosystems in Houston, Dallas-Fort Worth, Austin, and San Antonio. The Texas Medical Center and other major health systems support early evaluation of robotic technology, while suburban population growth creates additional demand for ambulatory surgery infrastructure. Texas was also the location of an important early U.S. deployment of a newer modular robotic surgical platform, highlighting the state’s relevance to commercial launch strategies.

Florida provides a different but equally attractive demand profile. Its large older-adult population supports high volumes of urologic, gynecologic, general, orthopedic, and cancer surgery. Hospitals across Miami, Tampa, Orlando, Jacksonville, and South Florida compete actively on advanced surgical capabilities, making robotic technology an important physician recruitment and service-line tool.

North Carolina has become increasingly important because of its combination of academic medicine, growing metropolitan populations, life-sciences investment, and sophisticated provider networks. Major hospital systems in the Research Triangle, Charlotte, and Winston-Salem support advanced robotic programs and clinical research.

Georgia and Tennessee provide substantial procedure opportunities around Atlanta, Nashville, Memphis, and other regional referral hubs. Nashville’s healthcare-services ecosystem is particularly relevant to commercialization because many multi-state hospital and ASC operators have strategic roots in the region.

Virginia and Maryland combine large commercially insured populations with major academic medical centers and proximity to federal healthcare and biomedical research infrastructure. Delaware is a smaller market but benefits from access to the broader Mid-Atlantic referral ecosystem.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, South Carolina, and West Virginia have smaller individual market values but remain strategically relevant. Several of these states have elevated obesity and chronic disease burdens, generating strong surgical demand. At the same time, rural access limitations can restrict the availability of highly specialized surgeons. Autonomous and remotely supportable robotic systems may therefore have long-term value if they can safely extend advanced procedural capabilities into regional hospitals.

The South’s large population, strong ASC development, disease burden, and continued migration to major metropolitan areas should allow it to remain the largest regional market throughout the forecast period.

West

The West represented approximately USD 0.78 billion in 2025 and is projected to reach approximately USD 4.74 billion by 2035, reflecting an estimated 19.8% CAGR, the highest among the four major U.S. regions.

The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.

California is the dominant state market in the region and one of the most strategically influential autonomous surgical robotics markets globally. The state combines large surgical volumes, internationally recognized medical centers, a deep AI and robotics workforce, venture funding, software engineering capability, and proximity to several major surgical robotics companies.

California’s significance extends beyond purchasing. Surgical robotics manufacturers can build engineering teams, collaborate with universities, conduct clinical validation, recruit AI specialists, and establish relationships with major health systems within the same innovation ecosystem. This combination gives California an outsized role in developing computer vision, surgical analytics, robotics software, and next-generation human-machine interfaces.

Arizona and Nevada are high-growth markets because of population migration and rising numbers of older residents. Phoenix, Scottsdale, Tucson, Las Vegas, and Reno are expanding surgical capacity, creating opportunities for orthopedic robotics, urologic robotics, and outpatient platforms.

Colorado and Utah benefit from relatively sophisticated integrated provider systems and technology-oriented clinical environments. Denver, Salt Lake City, and surrounding metropolitan areas are attractive markets for data-enabled robotic platforms because health systems increasingly evaluate technology at the enterprise level.

Washington and Oregon have strong academic hospitals and digitally mature health systems. Seattle is particularly relevant because of its broader technology ecosystem, which can facilitate collaboration between healthcare organizations and AI developers.

Idaho, Montana, Wyoming, Alaska, Hawaii, and New Mexico represent smaller markets but provide an important long-term use case for autonomy. Large geographic areas and specialist access limitations could strengthen demand for systems that simplify complex procedures, improve standardization, enable remote technical support, and reduce dependence on exceptionally high case volumes.

The West is expected to gain market share through 2035 because autonomous surgical robotics increasingly depends on software, AI, computer vision, cloud infrastructure, and data engineering—areas in which Western states have strong capabilities.

Northeast

The Northeast represented approximately USD 0.65 billion in 2025 and is expected to reach approximately USD 3.35 billion by 2035, reflecting an estimated 17.8% CAGR.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont.

New York is the region’s largest addressable state market. New York City has one of the country’s densest concentrations of complex surgical programs, major teaching hospitals, cancer centers, orthopedic centers, and subspecialty surgeons. Institutions such as Hospital for Special Surgery and large academic health systems create a powerful environment for orthopedic robotics and advanced surgical technology evaluation.

Massachusetts has a smaller population but exceptionally high strategic importance. Boston’s concentration of academic medical centers, engineering universities, medical-device research, biotechnology companies, and venture investment makes the state a critical innovation and clinical-validation market.

Pennsylvania combines major academic centers in Philadelphia and Pittsburgh with substantial community-hospital networks. The state is relevant across orthopedic, microsurgical, general surgical, neurological, and oncological robotic applications. Early U.S. microsurgical robotic procedures have also been conducted at major Pennsylvania institutions, demonstrating the region’s willingness to evaluate specialized robotic technologies.

New Jersey has a strong medtech and pharmaceutical industry base and benefits from proximity to both New York and Philadelphia. Large health systems and commercially insured populations support adoption of premium surgical technologies.

Connecticut and Rhode Island have smaller populations but high-quality academic and regional health systems capable of participating in early technology deployment. Maine, New Hampshire, and Vermont represent smaller revenue pools, although their rural populations illustrate potential future demand for automation that allows advanced procedures to be delivered closer to patients.

The Northeast’s overall CAGR is lower than the West because robotic surgery penetration is already relatively mature in many leading institutions. Nevertheless, the region will remain disproportionately influential in clinical trials, peer-reviewed evidence, surgeon training, regulatory submissions, and early adoption of high-complexity autonomous technologies.

Midwest

The Midwest represented approximately USD 0.48 billion in 2025 and is expected to reach approximately USD 2.51 billion by 2035, representing an estimated CAGR of approximately 18.0%.

The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin.

Illinois is one of the region’s largest markets because Chicago contains a dense network of major academic medical centers, community hospitals, and specialty programs. Health-system consolidation also supports enterprise robotics procurement rather than single-hospital purchasing.

Ohio is especially important to the competitive development of U.S. robotic surgery. Cleveland Clinic performed the first U.S. commercial case with the Hugo robotic-assisted surgery system in 2026, demonstrating the role of Midwestern academic centers in launching new robotic platforms.

Minnesota has outsized importance because of its historical medical-device ecosystem, surgical innovation culture, and major referral institutions. The state’s medtech infrastructure makes it relevant not only as a buyer but also as a development and commercialization hub.

Michigan, Indiana, Wisconsin, and Missouri support significant orthopedic and general surgical demand. Their mix of large academic systems, integrated delivery networks, and community facilities creates opportunities for both premium capital platforms and more cost-efficient next-generation robotic systems.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller absolute markets but offer a compelling longer-term autonomous robotics use case. Rural populations frequently depend on regional referral systems, and many community facilities cannot economically support every surgical subspecialty. Technologies that reduce procedural variability, simplify planning, and support standardized execution could eventually improve the feasibility of distributing complex care beyond major urban centers.

The Midwest is also particularly relevant to orthopedic automation because musculoskeletal procedure volumes are substantial and major orthopedic manufacturers maintain strong commercial relationships across the region. Adoption will depend heavily on demonstrable economic benefit, service reliability, surgeon training, and compatibility with existing implant contracts.

 

Key Market Players

The competitive landscape of the U.S. Autonomous Surgical Robotics Market is evolving from a market dominated by a small number of large robotic systems toward a multi-platform ecosystem combining established medtech companies, specialized robotic developers, AI companies, navigation providers, and procedure-specific innovators.

Some of the key participants influencing the U.S. market include Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Stryker, Zimmer Biomet, Smith+Nephew, Globus Medical, Brainlab, CMR Surgical, Distalmotion, Moon Surgical, Vicarious Surgical, Virtual Incision, Noah Medical, PROCEPT BioRobotics, THINK Surgical, Quantum Surgical, Medical Microinstruments, KARL STORZ/Asensus Surgical, Activ Surgical, Neocis, Accuray, and Renishaw.

Intuitive Surgical has the largest existing soft-tissue robotic ecosystem and possesses a significant strategic advantage because of its procedure data, installed base, surgeon relationships, instrument portfolio, and ability to introduce intelligent capabilities across an established platform.

Medtronic is emerging as an important U.S. competitor following FDA authorization and commercial introduction of Hugo, supported by the company’s broader surgical instrument, energy, stapling, visualization, and digital surgery portfolio. Real-time AI integration through its digital surgery infrastructure increases its relevance to the autonomous robotics segment.

Johnson & Johnson strengthened competition substantially when OTTAVA received U.S. authorization in 2026. Its scale in surgical instruments, energy, stapling, and hospital relationships provides substantial cross-selling potential.

Stryker and Zimmer Biomet are particularly influential in orthopedic robotics. Zimmer Biomet’s acquisition of Monogram Technologies materially increased its exposure to semi-autonomous and potentially fully autonomous joint replacement. Stryker’s established robotic orthopedic ecosystem provides a large installed base and deep procedural integration.

Smaller developers can compete successfully when they solve specific economic or workflow problems. Distalmotion is focused heavily on ambulatory robotic surgery. Virtual Incision addresses miniaturization and portability. CMR Surgical emphasizes modular architecture. Medical Microinstruments targets microsurgery. PROCEPT BioRobotics demonstrates how procedure-specific robotic automation can create an attractive differentiated market.

Competitive advantage through 2035 will increasingly depend on proprietary procedure datasets, FDA-cleared algorithms, clinically validated autonomous functions, installed-base utilization, consumable revenue, surgeon trust, cybersecurity, integration with imaging and surgical equipment, and the ability to demonstrate economic benefit to hospital value-analysis committees.

 

Recent Developments

Recent developments show that the U.S. robotic surgery market is entering its most competitive period in more than a decade.

In December 2025, Medtronic received FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures. The first U.S. commercial surgical case was completed at Cleveland Clinic in February 2026. Medtronic subsequently submitted additional FDA applications covering general and gynecological surgery, expanding the potential U.S. addressable procedure base.

In July 2026, Medtronic also introduced the next phase of its digital surgical strategy through real-time AI capabilities. An FDA-cleared computer-vision application was designed to provide visual notification when selected robotic instruments move beyond the visible operative field. This is strategically important because autonomous surgery will advance through incremental safety and perception capabilities before unrestricted autonomous execution becomes commercially viable.

Johnson & Johnson achieved another major milestone in July 2026, when the FDA granted De Novo marketing authorization to the OTTAVA Robotic Surgical System for multiple general surgery procedures in the upper abdomen. OTTAVA’s table-integrated architecture increases competitive pressure around operating-room footprint, workflow, and robotic setup.

CMR Surgical received U.S. FDA clearance for its Versius Plus system for cholecystectomy and subsequently pursued additional gynecologic indications. Its entry expands platform choice for hospitals evaluating alternatives to traditional large-console robotic architectures.

Distalmotion continued broadening the U.S. procedural portfolio of DEXTER. Following U.S. authorization for inguinal hernia repair, the company received additional clearances covering cholecystectomy, hysterectomy and gynecologic procedures, and ventral hernia repair. Its commercial positioning is particularly relevant to ASCs and outpatient surgery.

Virtual Incision’s MIRA miniaturized robotic platform received U.S. authorization for colectomy in 2024 and expanded into benign hysterectomy in 2026. The development illustrates how miniaturized robotics can reduce infrastructure requirements and broaden the number of facilities economically capable of offering robotic surgery.

Orthopedic autonomy is progressing especially rapidly. Monogram’s CT-based semi-autonomous total knee system received FDA clearance in March 2025. Zimmer Biomet completed the acquisition of Monogram in October 2025, and development of a surgeon-guided fully autonomous version has continued through clinical investigation. Zimmer Biomet also received FDA clearance for an enhanced ROSA Knee platform incorporating automated planning features.

Robotic microsurgery is becoming another specialized growth field. Medical Microinstruments obtained U.S. De Novo authorization for the Symani Surgical System in 2024 and subsequently expanded its instrument capabilities, supporting progressively more complex microsurgical tasks.

Taken together, these developments indicate that competition is moving simultaneously in three directions: greater platform choice, smaller and more flexible robotic architectures, and progressively higher levels of software intelligence and automation.

 

Conclusion

The U.S. Autonomous Surgical Robotics Market Size & Share is positioned for rapid expansion from approximately USD 2.84 billion in 2025 to USD 15.51 billion by 2035, representing a CAGR of approximately 18.50% during 2026–2035.

The market’s growth should not be interpreted as evidence that fully independent robotic surgery will become routine in the immediate future. The dominant commercial opportunity is supervised and task-level autonomy. Surgical robots will increasingly automate planning, alignment, navigation, anatomical recognition, instrument monitoring, bone preparation, trajectory execution, tissue treatment, and other controlled procedural functions while physicians remain responsible for clinical decisions.

Orthopedic surgery offers the clearest near-term pathway toward higher autonomy because anatomical geometry can be modeled and robotic execution can be constrained within predictable boundaries. Soft-tissue robotics represents the largest longer-term opportunity because of the enormous procedure base, but technical complexity and regulatory requirements will favor incremental automation.

General surgery, urology, gynecology, orthopedic surgery, neurosurgery, spine surgery, microsurgery, interventional oncology, and endoluminal procedures will create multiple parallel value pools rather than a single dominant autonomous surgery category.

Hospitals will remain the largest customers, but ASCs will become increasingly important as miniaturized and modular robotics improve site-of-care economics. Manufacturers capable of reducing footprint, setup time, staffing requirements, capital intensity, and disposable cost will have an advantage as more surgery moves outside traditional inpatient hospitals.

Geographically, the South will remain the largest regional market because of population scale, disease burden, expanding hospital networks, and growing outpatient capacity. The West should record the fastest growth because of its concentration of AI, robotics, software, venture capital, academic medicine, and advanced medtech development. The Northeast will remain critically important for clinical evidence generation, while the Midwest will provide a durable market anchored by orthopedic surgery, major referral centers, and integrated delivery networks.

For manufacturers, investors, hospitals, and strategic buyers evaluating this market, the most important question is not when a robot will conduct an entire operation independently. The commercially relevant question is which individual surgical tasks can be automated safely, reproducibly, economically, and at sufficient procedure scale to justify adoption.

Companies that answer that question with credible clinical data, robust regulatory strategies, surgeon-centered system design, defensible procedure datasets, transparent AI, strong cybersecurity, scalable service infrastructure, and clear hospital economics will define the U.S. autonomous surgical robotics market through 2035.

 

TABLE OF CONTENT

1. U.S. Autonomous Surgical Robotics Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Bottom-Up & Top-Down Modeling
1.3.6. Autonomous Surgical Robotics Revenue Attribution Framework
1.3.7. Analytical Frameworks & Forecasting Models
1.3.8. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Autonomous Surgical Robotics Market Boundary
1.5.1. Surgeon-Controlled Robotic Assistance
1.5.2. Intelligent Robotic Assistance
1.5.3. Task-Level Autonomous Execution
1.5.4. Supervised High-Autonomy Surgery
1.5.5. Fully Autonomous Surgery
1.6. Market Ecosystem Overview
1.7. Stakeholder Analysis
1.7.1. Surgical Robotics Manufacturers
1.7.2. AI, Computer Vision and Surgical Software Developers
1.7.3. Robotic Components, Sensors and Precision Motion Suppliers
1.7.4. Surgical Instrument and Consumable Manufacturers
1.7.5. Hospitals and Integrated Delivery Networks
1.7.6. Academic and Teaching Medical Centers
1.7.7. Ambulatory Surgery Centers and Specialty Surgical Facilities
1.7.8. Surgeons and Clinical Decision-Makers
1.7.9. Group Purchasing Organizations and Capital Equipment Committees
1.7.10. Payers, FDA and Other Regulatory Stakeholders

What this section provides: This section defines the U.S. autonomous surgical robotics market boundary, research methodology, revenue-attribution logic, autonomy spectrum, assumptions, and stakeholder ecosystem so clients understand precisely how the market is measured and validated.

2. U.S. Autonomous Surgical Robotics Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025 vs. 2035
2.8. Autonomous Surgery Adoption Curve
2.9. High-Growth Opportunity Areas
2.10. Highest-Potential Surgical Specialties
2.11. Hospital and ASC Adoption Outlook
2.12. Key Strategic Takeaways for Manufacturers and Investors

What this section provides: This section gives decision-makers a concise view of market size, CAGR, adoption maturity, major surgical applications, autonomy progression, competitive intensity, regional opportunities, and priority investment areas.

3. U.S. Autonomous Surgical Robotics Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rapid Expansion of Robotic-Assisted Surgical Procedure Volumes
3.1.2. Growing Demand for Standardized and Reproducible Surgical Outcomes
3.1.3. Increasing Integration of AI and Computer Vision into Surgical Robotics
3.1.4. U.S. Surgeon Workforce Constraints and Productivity Requirements
3.1.5. Growth of Robotic Orthopedic and Joint Replacement Procedures
3.1.6. Increasing Hospital Investment in Digital and Robotic Operating Rooms
3.1.7. Migration of Suitable Procedures Toward Ambulatory Surgery Centers
3.1.8. Rising Demand for Patient-Specific Surgical Planning
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Lifecycle Costs
3.2.2. Limited Clinical Validation of Higher Levels of Surgical Autonomy
3.2.3. Regulatory Complexity for AI-Enabled Robotic Systems
3.2.4. Surgeon Trust and Clinical Adoption Barriers
3.2.5. Liability and Accountability Concerns in Autonomous Execution
3.2.6. Cybersecurity and Connected-Device Risks
3.2.7. Operating Room Integration and Infrastructure Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Semi-Autonomous and Autonomous Orthopedic Bone Preparation
3.3.2. AI-Based Surgical Planning and Anatomy Recognition
3.3.3. Automated Instrument Safety and Surgical Workflow Monitoring
3.3.4. Autonomous Camera Control and Visualization
3.3.5. Task-Level Automation in Soft-Tissue Surgery
3.3.6. Robotic Microsurgery and Precision Procedures
3.3.7. Autonomous Image-Guided and Interventional Procedures
3.3.8. Miniaturized Robotics for Ambulatory Surgery Centers
3.3.9. Software Upgrades Across Existing Robotic Installed Bases
3.4. Challenges and Their Impact Analysis
3.4.1. Real-Time Decision-Making in Deformable Soft Tissue
3.4.2. Surgical Dataset Quality and Algorithm Generalizability
3.4.3. Demonstrating Clinical Superiority Over Conventional Robotics
3.4.4. Workflow Standardization Across Hospital Systems
3.4.5. Training Surgeons for Human-Robot Supervisory Workflows
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Surgical Procedure Automation Opportunity Analysis
3.7. Clinical Workflow Economics Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Robotic Procedure Cost and Utilization Economics
3.10. Surgeon Learning Curve and Training Economics

What this section provides: This section explains the clinical, technological, regulatory, workforce, financial, and operational forces shaping autonomous surgical robotics adoption and identifies the highest-value opportunities and commercialization risks.

4. U.S. Autonomous Surgical Robotics Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital Buyers
4.2.3. Bargaining Power of Technology and Component Suppliers
4.2.4. Threat of Conventional and Non-Robotic Surgical Substitution
4.2.5. Competitive Rivalry
4.3. Surgical Robotics Pricing Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Surgical Robotics Hardware and Component Ecosystem
4.6. AI, Computer Vision and Surgical Data Ecosystem
4.7. FDA Regulatory Framework Analysis
4.7.1. 510(k) Pathway Considerations
4.7.2. De Novo Pathway Considerations
4.7.3. PMA Considerations for Higher-Risk Applications
4.7.4. Software as a Medical Device Considerations
4.7.5. AI/ML-Enabled Device Modification Considerations
4.7.6. Human Factors and Surgeon Override Requirements
4.8. CMS Reimbursement and Coverage Landscape
4.9. Hospital and ASC Procedure Economics
4.10. Cybersecurity and Connected Surgical Device Requirements
4.11. Surgical Data Governance and Privacy Considerations
4.12. Import/Export Restrictions & Tariff Impact
4.13. Impact of Semiconductor, Sensor and Precision Component Supply
4.14. Impact of Escalating Geopolitical Tensions
4.15. Hospital Value Analysis Committee Decision Framework
4.16. Robotic System Lifecycle Cost Analysis

What this section provides: This section provides a comprehensive view of the regulatory, reimbursement, technological, economic, supply-chain, cybersecurity, and hospital procurement environment determining the commercialization potential of autonomous surgical robotics.

5. U.S. Autonomous Surgical Robotics Market – By System Type

5.1. Overview
5.1.1. Segment Share Analysis, By System Type, 2025 & 2035 (%)
5.1.2. Soft-Tissue Robotic Surgical Platforms
5.1.3. Orthopedic Robotic Surgical Systems
5.1.4. Spine and Neurosurgical Robotic Systems
5.1.5. Endoluminal and Image-Guided Interventional Robotic Systems
5.1.6. Microsurgery and Specialty Robotic Systems

What this section provides: This section identifies which autonomous robotic system categories are expected to generate the greatest U.S. revenue contribution, procedure penetration, and technology-led growth through 2035.

6. U.S. Autonomous Surgical Robotics Market – By Level of Autonomy

6.1. Overview
6.1.1. Segment Share Analysis, By Level of Autonomy, 2025 & 2035 (%)
6.1.2. Intelligent Assistance and Low-Level Autonomy
6.1.2.1. Automated Surgical Planning
6.1.2.2. Virtual Boundaries and Robotic Constraints
6.1.2.3. AI-Based Safety Monitoring
6.1.2.4. Automated Camera and Visualization Assistance
6.1.3. Task-Level and Conditional Autonomy
6.1.3.1. Automated Bone Preparation
6.1.3.2. Automated Trajectory Execution
6.1.3.3. Robotically Controlled Tissue Resection
6.1.3.4. Automated Instrument Positioning
6.1.4. Supervised High Autonomy
6.1.4.1. Surgeon-Approved Autonomous Procedure Steps
6.1.4.2. Closed-Loop Robotic Execution
6.1.4.3. Automated Verification and Error Detection
6.1.5. Fully Autonomous Surgical Systems
6.1.5.1. Preclinical Autonomous Surgical Platforms
6.1.5.2. Investigational Human Clinical Systems
6.1.5.3. Future Commercial Autonomous Platforms

What this section provides: This section evaluates the market across the surgical autonomy continuum and shows how value is expected to migrate from intelligent assistance toward task-level and supervised autonomous execution.

7. U.S. Autonomous Surgical Robotics Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Orthopedic Surgery
7.1.2.1. Total Knee Arthroplasty
7.1.2.2. Total Hip Arthroplasty
7.1.2.3. Partial Knee Arthroplasty
7.1.2.4. Other Orthopedic Procedures
7.1.3. General Surgery
7.1.3.1. Hernia Repair
7.1.3.2. Colorectal Surgery
7.1.3.3. Cholecystectomy
7.1.3.4. Bariatric Surgery
7.1.3.5. Other General Surgical Procedures
7.1.4. Urology
7.1.4.1. Prostatectomy
7.1.4.2. Nephrectomy and Partial Nephrectomy
7.1.4.3. Benign Prostatic Hyperplasia Procedures
7.1.4.4. Other Urological Procedures
7.1.5. Gynecologic Surgery
7.1.5.1. Hysterectomy
7.1.5.2. Endometriosis Surgery
7.1.5.3. Sacrocolpopexy
7.1.5.4. Other Gynecologic Procedures
7.1.6. Neurosurgery and Spine Surgery
7.1.6.1. Spinal Instrumentation
7.1.6.2. Stereotactic Neurosurgery
7.1.6.3. Cranial Procedures
7.1.6.4. Other Neurological Procedures
7.1.7. Other Applications
7.1.7.1. Thoracic Surgery
7.1.7.2. Microsurgery
7.1.7.3. Robotic Bronchoscopy
7.1.7.4. Interventional Oncology
7.1.7.5. ENT and Specialty Surgery

What this section provides: This section helps clients identify the surgical specialties and procedure groups with the greatest addressable opportunity for autonomous execution, robotic workflow automation, and AI-enabled procedure standardization.

8. U.S. Autonomous Surgical Robotics Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Large Integrated Delivery Networks
8.1.2.2. Community Hospitals
8.1.2.3. Regional Referral Hospitals
8.1.3. Academic and Teaching Medical Centers
8.1.4. Ambulatory Surgery Centers
8.1.4.1. Independent ASCs
8.1.4.2. Hospital-Owned ASCs
8.1.4.3. Physician-Owned ASCs
8.1.5. Specialty Surgical Hospitals and Centers
8.1.5.1. Orthopedic Specialty Centers
8.1.5.2. Urology and Surgical Specialty Centers
8.1.5.3. Microsurgery and Specialty Procedure Centers
8.1.6. Federal, Veterans and Other Public Healthcare Facilities

What this section provides: This section explains which U.S. care settings are expected to lead autonomous surgical robotics purchasing, procedure utilization, clinical validation, and outpatient adoption through 2035.

9. U.S. Autonomous Surgical Robotics Market: Adoption Economics, Procurement & Deployment Analysis

9.1. Overview
9.2. Hospital Robotic Surgery Capital Budget Analysis
9.3. Robotic System Acquisition Economics
9.4. Capital Purchase Models
9.5. Leasing and Financing Models
9.6. Usage-Based and Procedure-Based Commercial Models
9.7. Robotics-as-a-Service Opportunity
9.8. Consumables and Recurring Instrument Revenue
9.9. Software Subscription and AI Upgrade Revenue
9.10. Service and Maintenance Revenue
9.11. Integrated Delivery Network Enterprise Procurement
9.12. Group Purchasing Organization Influence
9.13. Surgeon Champion and Clinical Committee Influence
9.14. Hospital Value Analysis Committee Evaluation Criteria
9.15. Capital Payback and Utilization Threshold Analysis
9.16. Operating Room Throughput Economics
9.17. ASC Robotic Surgery Economics
9.18. Total Cost of Ownership Analysis
9.19. Clinical Evidence Requirements for Capital Approval
9.20. Procurement Outlook, 2026–2035

What this section provides: This section helps clients understand how autonomous surgical robotics systems are funded, evaluated, contracted, deployed, and economically justified across hospitals, IDNs, specialty centers, and ASCs without introducing an additional market segmentation dimension.

10. U.S. Autonomous Surgical Robotics Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Robotic Surgical Procedure Volume Analysis
10.1.4. Regional Robotic Surgery Installed Base Analysis
10.1.5. Regional Hospital and ASC Infrastructure Analysis
10.1.6. Regional Academic Medical Center and Innovation Hub Analysis
10.1.7. Regional Capital Procurement and Adoption Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Autonomous Surgical Robotics Manufacturers, Innovation Hubs and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. California
10.2.8.1. Overview
10.2.8.2. California Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.8.3. California Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.8.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.8.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9. Washington
10.2.9.1. Overview
10.2.9.2. Washington Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.9.3. Washington Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.9.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10. Arizona
10.2.10.1. Overview
10.2.10.2. Arizona Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.10.3. Arizona Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.10.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11. Colorado
10.2.11.1. Overview
10.2.11.2. Colorado Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.11.3. Colorado Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.11.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12. Oregon
10.2.12.1. Overview
10.2.12.2. Oregon Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.12.3. Oregon Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.12.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13. Utah
10.2.13.1. Overview
10.2.13.2. Utah Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.13.3. Utah Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.13.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14. Nevada
10.2.14.1. Overview
10.2.14.2. Nevada Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.14.3. Nevada Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.14.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15. New Mexico
10.2.15.1. Overview
10.2.15.2. New Mexico Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.15.3. New Mexico Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.15.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16. Idaho
10.2.16.1. Overview
10.2.16.2. Idaho Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.16.3. Idaho Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.16.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17. Montana
10.2.17.1. Overview
10.2.17.2. Montana Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.17.3. Montana Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.17.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18. Wyoming
10.2.18.1. Overview
10.2.18.2. Wyoming Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.18.3. Wyoming Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.18.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19. Alaska
10.2.19.1. Overview
10.2.19.2. Alaska Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.19.3. Alaska Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.19.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20. Hawaii
10.2.20.1. Overview
10.2.20.2. Hawaii Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.2.20.3. Hawaii Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.2.20.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Autonomous Surgical Robotics Manufacturers, Academic Centers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. New York
10.3.8.1. Overview
10.3.8.2. New York Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.8.3. New York Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.8.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.8.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9. Massachusetts
10.3.9.1. Overview
10.3.9.2. Massachusetts Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.9.3. Massachusetts Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.9.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10. New Jersey
10.3.10.1. Overview
10.3.10.2. New Jersey Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.10.3. New Jersey Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.10.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11. Pennsylvania
10.3.11.1. Overview
10.3.11.2. Pennsylvania Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.11.3. Pennsylvania Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.11.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12. Connecticut
10.3.12.1. Overview
10.3.12.2. Connecticut Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.12.3. Connecticut Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.12.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13. Maine
10.3.13.1. Overview
10.3.13.2. Maine Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.13.3. Maine Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.13.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14. Vermont
10.3.14.1. Overview
10.3.14.2. Vermont Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.14.3. Vermont Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.14.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15. New Hampshire
10.3.15.1. Overview
10.3.15.2. New Hampshire Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.15.3. New Hampshire Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.15.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16. Rhode Island
10.3.16.1. Overview
10.3.16.2. Rhode Island Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.16.3. Rhode Island Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.16.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17. Delaware
10.3.17.1. Overview
10.3.17.2. Delaware Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.3.17.3. Delaware Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.3.17.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Autonomous Surgical Robotics Manufacturers, Hospital Systems and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. Texas
10.4.8.1. Overview
10.4.8.2. Texas Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.8.3. Texas Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.8.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.8.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9. Florida
10.4.9.1. Overview
10.4.9.2. Florida Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.9.3. Florida Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.9.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10. Georgia
10.4.10.1. Overview
10.4.10.2. Georgia Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.10.3. Georgia Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.10.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11. North Carolina
10.4.11.1. Overview
10.4.11.2. North Carolina Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.11.3. North Carolina Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.11.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12. Tennessee
10.4.12.1. Overview
10.4.12.2. Tennessee Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.12.3. Tennessee Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.12.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13. South Carolina
10.4.13.1. Overview
10.4.13.2. South Carolina Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.13.3. South Carolina Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.13.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14. Alabama
10.4.14.1. Overview
10.4.14.2. Alabama Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.14.3. Alabama Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.14.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15. Mississippi
10.4.15.1. Overview
10.4.15.2. Mississippi Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.15.3. Mississippi Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.15.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16. Louisiana
10.4.16.1. Overview
10.4.16.2. Louisiana Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.16.3. Louisiana Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.16.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17. Arkansas
10.4.17.1. Overview
10.4.17.2. Arkansas Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.17.3. Arkansas Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.17.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18. Kentucky
10.4.18.1. Overview
10.4.18.2. Kentucky Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.18.3. Kentucky Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.18.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19. Oklahoma
10.4.19.1. Overview
10.4.19.2. Oklahoma Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.19.3. Oklahoma Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.19.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20. Virginia
10.4.20.1. Overview
10.4.20.2. Virginia Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.20.3. Virginia Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.20.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21. Maryland
10.4.21.1. Overview
10.4.21.2. Maryland Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.21.3. Maryland Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.21.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22. West Virginia
10.4.22.1. Overview
10.4.22.2. West Virginia Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.4.22.3. West Virginia Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.4.22.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Autonomous Surgical Robotics Manufacturers, Medtech Ecosystem and Procurement Landscape
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Illinois
10.5.8.1. Overview
10.5.8.2. Illinois Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.8.3. Illinois Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.8.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.8.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9. Ohio
10.5.9.1. Overview
10.5.9.2. Ohio Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.9.3. Ohio Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.9.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10. Michigan
10.5.10.1. Overview
10.5.10.2. Michigan Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.10.3. Michigan Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.10.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11. Minnesota
10.5.11.1. Overview
10.5.11.2. Minnesota Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.11.3. Minnesota Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.11.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12. Indiana
10.5.12.1. Overview
10.5.12.2. Indiana Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.12.3. Indiana Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.12.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13. Wisconsin
10.5.13.1. Overview
10.5.13.2. Wisconsin Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.13.3. Wisconsin Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.13.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14. Missouri
10.5.14.1. Overview
10.5.14.2. Missouri Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.14.3. Missouri Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.14.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15. Iowa
10.5.15.1. Overview
10.5.15.2. Iowa Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.15.3. Iowa Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.15.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16. Kansas
10.5.16.1. Overview
10.5.16.2. Kansas Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.16.3. Kansas Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.16.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17. Nebraska
10.5.17.1. Overview
10.5.17.2. Nebraska Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.17.3. Nebraska Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.17.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18. North Dakota
10.5.18.1. Overview
10.5.18.2. North Dakota Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.18.3. North Dakota Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.18.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19. South Dakota
10.5.19.1. Overview
10.5.19.2. South Dakota Market Size and Forecast, By System Type, 2021–2035 (US$ Billion)
10.5.19.3. South Dakota Market Size and Forecast, By Level of Autonomy, 2021–2035 (US$ Billion)
10.5.19.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level market analysis across all 50 states, helping clients identify robotic surgery adoption hotspots, academic innovation hubs, high-volume surgical markets, outpatient opportunities, capital procurement centers, and state-level commercial opportunities.

11. U.S. Autonomous Surgical Robotics Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Robotic Installed Base
11.2.2. Surgical Procedure Coverage
11.2.3. Level of Automation
11.2.4. AI and Computer Vision Capabilities
11.2.5. FDA-Cleared Indications
11.2.6. Capital and Recurring Revenue Model
11.2.7. Hospital and ASC Positioning
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Company Profiles
11.4.1. Intuitive Surgical
11.4.2. Medtronic
11.4.3. Johnson & Johnson MedTech
11.4.4. Stryker
11.4.5. Zimmer Biomet
11.4.6. Smith+Nephew
11.4.7. Globus Medical
11.4.8. Brainlab
11.4.9. CMR Surgical
11.4.10. Distalmotion
11.4.11. Moon Surgical
11.4.12. Vicarious Surgical
11.4.13. Virtual Incision
11.4.14. Noah Medical
11.4.15. PROCEPT BioRobotics
11.4.16. THINK Surgical
11.4.17. Quantum Surgical
11.4.18. Medical Microinstruments
11.4.19. KARL STORZ / Asensus Surgical
11.4.20. Activ Surgical
11.4.21. Neocis
11.4.22. Accuray
11.4.23. Renishaw

Note: Each company profile will include company overview, autonomous and robotic surgical portfolio, level of autonomy, U.S. market strategy, installed-base positioning, application coverage, AI and software capabilities, regulatory status, financial and commercial positioning, clinical pipeline, partnerships, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, autonomy positioning, robotic platform differentiation, procedure coverage, AI capability assessment, regulatory progress, and strategic intelligence on leading and emerging surgical robotics companies.

12. U.S. Autonomous Surgical Robotics Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Surgical Autonomy Evolution, 2026–2035
12.2.1. From Robotic Assistance to Intelligent Assistance
12.2.2. From Intelligent Assistance to Task-Level Autonomy
12.2.3. From Task-Level Autonomy to Supervised High Autonomy
12.2.4. Long-Term Path Toward Fully Autonomous Surgery
12.3. Disruptive Technologies Impact
12.3.1. Surgical Computer Vision
12.3.2. Generative and Multimodal AI for Surgical Planning
12.3.3. Automated Anatomy Recognition
12.3.4. Real-Time Surgical Scene Understanding
12.3.5. Autonomous Robotic Bone Preparation
12.3.6. Automated Suturing and Tissue Manipulation
12.3.7. Digital Surgical Twins
12.3.8. Augmented and Mixed Reality Guidance
12.3.9. Advanced Haptics and Force Sensing
12.3.10. Miniaturized and Modular Surgical Robotics
12.3.11. Cloud-Connected Surgical Intelligence
12.4. Emerging Business Trends
12.5. Shift Toward Software-Defined Surgical Robotics
12.6. Recurring Software and AI Revenue Opportunity
12.7. Procedure-Based Robotics Business Models
12.8. Expansion into Ambulatory Surgery Centers
12.9. Business Opportunities for Startups and Existing Players
12.10. Investment Prioritization Matrix
12.11. High-Potential Technology-Application Matrix
12.12. Autonomous Surgery Commercialization Roadmap Through 2035

What this section provides: This section prepares clients for the evolution of surgical autonomy, disruptive technology shifts, changing robotic business models, high-growth application areas, emerging investment opportunities, and realistic commercialization scenarios through 2035.

13. U.S. Autonomous Surgical Robotics Market: Strategic Recommendations

13.1. Recommendations for Surgical Robotics Manufacturers
13.2. Recommendations for AI and Surgical Software Developers
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Ambulatory Surgery Centers
13.5. Recommendations for Surgeons and Clinical Program Leaders
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Medical Device Strategic Buyers
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. FDA and Clinical Evidence Strategy Considerations
13.11. Hospital Capital Procurement Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. Partnership, Licensing and M&A Opportunity Framework
13.14. U.S. State and Regional Market Prioritization Strategy
13.15. ASC Commercialization Strategy
13.16. Pricing and Recurring Revenue Strategy
13.17. Surgeon Training and Adoption Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, regulatory strategy, U.S. commercialization, capital procurement, clinical adoption, geographic expansion, partnerships, M&A, pricing, and competitive differentiation.

14. U.S. Autonomous Surgical Robotics Market: Disclaimer

14.1. Scope Limitation
14.2. Autonomous Surgical Robotics Definition Limitation
14.3. Market Revenue Attribution Limitation
14.4. Data Use Limitation
14.5. Forecasting Limitation
14.6. Emerging Technology and Clinical Development Limitation
14.7. Regulatory Status Limitation
14.8. Legal Disclaimer
14.9. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s market-definition boundaries, autonomous robotics revenue-attribution methodology, data and forecasting limitations, regulatory uncertainties, legal boundaries, and third-party information considerations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Autonomous Surgical Robotics Market: Market Definition and Scope
TABLE 3: U.S. Autonomous Surgical Robotics Market: Research Methodology Framework
TABLE 4: U.S. Autonomous Surgical Robotics Market: Key Assumptions
TABLE 5: U.S. Autonomous Surgical Robotics Market: Autonomous Surgery Market Boundary and Classification
TABLE 6: U.S. Autonomous Surgical Robotics Market: Market Ecosystem and Stakeholder Analysis
TABLE 7: U.S. Autonomous Surgical Robotics Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Autonomous Surgical Robotics Market: Analyst Viewpoint Summary
TABLE 9: U.S. Autonomous Surgical Robotics Market: Market Attractiveness Index
TABLE 10: U.S. Autonomous Surgical Robotics Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Autonomous Surgical Robotics Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Autonomous Surgical Robotics Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Autonomous Surgical Robotics Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Autonomous Surgical Robotics Market: Drivers; Impact Analysis
TABLE 15: U.S. Autonomous Surgical Robotics Market: Restraints; Impact Analysis
TABLE 16: U.S. Autonomous Surgical Robotics Market: Opportunities; Impact Analysis
TABLE 17: U.S. Autonomous Surgical Robotics Market: Challenges; Impact Analysis
TABLE 18: U.S. Autonomous Surgical Robotics Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Autonomous Surgical Robotics Market: Surgical Procedure Automation Opportunity Matrix
TABLE 20: U.S. Autonomous Surgical Robotics Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Autonomous Surgical Robotics Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Autonomous Surgical Robotics Market: Robotic Procedure Cost and Utilization Economics
TABLE 23: U.S. Autonomous Surgical Robotics Market: Surgeon Learning Curve and Training Economics
TABLE 24: U.S. Autonomous Surgical Robotics Market: PESTEL Analysis
TABLE 25: U.S. Autonomous Surgical Robotics Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Autonomous Surgical Robotics Market: Surgical Robotics Pricing Trend Analysis, 2025–2035
TABLE 27: U.S. Autonomous Surgical Robotics Market: Value Chain Analysis
TABLE 28: U.S. Autonomous Surgical Robotics Market: Supply Chain Analysis
TABLE 29: U.S. Autonomous Surgical Robotics Market: Surgical Robotics Hardware and Component Ecosystem
TABLE 30: U.S. Autonomous Surgical Robotics Market: AI, Computer Vision and Surgical Data Ecosystem
TABLE 31: U.S. Autonomous Surgical Robotics Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Autonomous Surgical Robotics Market: AI/ML-Enabled Robotic Device Regulatory Considerations
TABLE 33: U.S. Autonomous Surgical Robotics Market: CMS Reimbursement and Coverage Landscape
TABLE 34: U.S. Autonomous Surgical Robotics Market: Hospital and ASC Procedure Economics
TABLE 35: U.S. Autonomous Surgical Robotics Market: Cybersecurity and Surgical Data Governance Matrix
TABLE 36: U.S. Autonomous Surgical Robotics Market: Supply Chain, Tariff and Geopolitical Impact
TABLE 37: U.S. Autonomous Surgical Robotics Market: Hospital Value Analysis Committee Decision Framework
TABLE 38: U.S. Autonomous Surgical Robotics Market: System Type Snapshot, 2025
TABLE 39: Segment Dashboard; Definition and Scope, by System Type
TABLE 40: U.S. Autonomous Surgical Robotics Market, by System Type, 2021–2035 (US$ Billion)
TABLE 41: U.S. Autonomous Surgical Robotics Market: Segment Share Analysis, by System Type, 2025 & 2035 (%)
TABLE 42: Soft-Tissue Robotic Surgical Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Orthopedic Robotic Surgical Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Spine and Neurosurgical Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Endoluminal and Image-Guided Interventional Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Microsurgery and Specialty Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Autonomous Surgical Robotics Market: Level of Autonomy Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Level of Autonomy
TABLE 49: U.S. Autonomous Surgical Robotics Market, by Level of Autonomy, 2021–2035 (US$ Billion)
TABLE 50: U.S. Autonomous Surgical Robotics Market: Segment Share Analysis, by Level of Autonomy, 2025 & 2035 (%)
TABLE 51: Intelligent Assistance and Low-Level Autonomy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Task-Level and Conditional Autonomy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Supervised High Autonomy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Fully Autonomous Surgical Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Autonomous Surgical Robotics Market: Application Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by Application
TABLE 57: U.S. Autonomous Surgical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 58: U.S. Autonomous Surgical Robotics Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 59: Orthopedic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: General Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Urology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Gynecologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Neurosurgery and Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Thoracic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Microsurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Robotic Bronchoscopy and Interventional Oncology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Autonomous Surgical Robotics Market: End User Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by End User
TABLE 69: U.S. Autonomous Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 70: U.S. Autonomous Surgical Robotics Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 71: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Academic and Teaching Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Specialty Surgical Hospitals and Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Federal, Veterans and Other Public Healthcare Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Autonomous Surgical Robotics Market: Hospital Robotic Surgery Capital Budget Analysis
TABLE 77: U.S. Autonomous Surgical Robotics Market: Robotic System Acquisition Economics
TABLE 78: U.S. Autonomous Surgical Robotics Market: Capital Purchase, Leasing and Financing Model Comparison
TABLE 79: U.S. Autonomous Surgical Robotics Market: Usage-Based and Procedure-Based Commercial Models
TABLE 80: U.S. Autonomous Surgical Robotics Market: Robotics-as-a-Service Opportunity
TABLE 81: U.S. Autonomous Surgical Robotics Market: Consumables and Recurring Instrument Revenue
TABLE 82: U.S. Autonomous Surgical Robotics Market: Software Subscription and AI Upgrade Revenue
TABLE 83: U.S. Autonomous Surgical Robotics Market: Service and Maintenance Revenue
TABLE 84: U.S. Autonomous Surgical Robotics Market: IDN and GPO Procurement Dynamics
TABLE 85: U.S. Autonomous Surgical Robotics Market: Capital Payback and Utilization Threshold Analysis
TABLE 86: U.S. Autonomous Surgical Robotics Market: Operating Room Throughput Economics
TABLE 87: U.S. Autonomous Surgical Robotics Market: ASC Robotic Surgery Economics
TABLE 88: U.S. Autonomous Surgical Robotics Market: Total Cost of Ownership Analysis
TABLE 89: U.S. Autonomous Surgical Robotics Market: Regional Snapshot, 2025
TABLE 90: Segment Dashboard; Definition and Scope, by Geography
TABLE 91: U.S. Autonomous Surgical Robotics Market, by Region, 2021–2035 (US$ Billion)
TABLE 92: U.S. Autonomous Surgical Robotics Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 93: U.S. Autonomous Surgical Robotics Market: Regional Robotic Surgical Procedure Volume Analysis
TABLE 94: U.S. Autonomous Surgical Robotics Market: Regional Hospital, ASC and Installed Base Analysis
TABLE 95: West Region U.S. Autonomous Surgical Robotics Market: Regional Overview and Trends
TABLE 96: West Region U.S. Autonomous Surgical Robotics Market: Manufacturers, Innovation Hubs and Procurement Ecosystem
TABLE 97: West Region U.S. Autonomous Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Autonomous Surgical Robotics Market, by System Type, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Autonomous Surgical Robotics Market, by Level of Autonomy, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Autonomous Surgical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Autonomous Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Washington Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Arizona Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Colorado Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Oregon Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Utah Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Nevada Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: New Mexico Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Idaho Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Montana Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Wyoming Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Alaska Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Hawaii Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Autonomous Surgical Robotics Market: Regional Overview and Trends
TABLE 116: Northeast Region U.S. Autonomous Surgical Robotics Market: Manufacturers, Academic Centers and Procurement Ecosystem
TABLE 117: Northeast Region U.S. Autonomous Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Autonomous Surgical Robotics Market, by System Type, 2021–2035 (US$ Billion)
TABLE 119: Northeast Region U.S. Autonomous Surgical Robotics Market, by Level of Autonomy, 2021–2035 (US$ Billion)
TABLE 120: Northeast Region U.S. Autonomous Surgical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region U.S. Autonomous Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: New York Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Massachusetts Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: New Jersey Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Pennsylvania Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Connecticut Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Maine Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Vermont Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: New Hampshire Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Rhode Island Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Delaware Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Autonomous Surgical Robotics Market: Regional Overview and Trends
TABLE 133: South Region U.S. Autonomous Surgical Robotics Market: Manufacturers, Hospital Systems and Procurement Ecosystem
TABLE 134: South Region U.S. Autonomous Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Autonomous Surgical Robotics Market, by System Type, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. Autonomous Surgical Robotics Market, by Level of Autonomy, 2021–2035 (US$ Billion)
TABLE 137: South Region U.S. Autonomous Surgical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: South Region U.S. Autonomous Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Texas Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Florida Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Georgia Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: North Carolina Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Tennessee Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: South Carolina Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Alabama Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Mississippi Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Louisiana Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Arkansas Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Kentucky Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Oklahoma Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Virginia Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Maryland Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: West Virginia Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Midwest Region U.S. Autonomous Surgical Robotics Market: Regional Overview and Trends
TABLE 155: Midwest Region U.S. Autonomous Surgical Robotics Market: Manufacturers, Medtech Ecosystem and Procurement Landscape
TABLE 156: Midwest Region U.S. Autonomous Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Autonomous Surgical Robotics Market, by System Type, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Autonomous Surgical Robotics Market, by Level of Autonomy, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. Autonomous Surgical Robotics Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Midwest Region U.S. Autonomous Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Illinois Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Ohio Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Michigan Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Minnesota Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Indiana Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Wisconsin Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Missouri Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Iowa Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Kansas Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Nebraska Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: North Dakota Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: South Dakota Autonomous Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: U.S. Autonomous Surgical Robotics Market: Competitive Landscape Snapshot, 2025
TABLE 174: U.S. Autonomous Surgical Robotics Market: Key Company Market Share Analysis, 2025
TABLE 175: U.S. Autonomous Surgical Robotics Market: Company Positioning Matrix
TABLE 176: U.S. Autonomous Surgical Robotics Market: Robotic Platform and Procedure Portfolio Benchmarking
TABLE 177: U.S. Autonomous Surgical Robotics Market: Autonomy, AI and Computer Vision Capability Benchmarking
TABLE 178: U.S. Autonomous Surgical Robotics Market: FDA-Cleared Indication Benchmarking
TABLE 179: U.S. Autonomous Surgical Robotics Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 180: Intuitive Surgical: Company Profile
TABLE 181: Medtronic: Company Profile
TABLE 182: Johnson & Johnson MedTech: Company Profile
TABLE 183: Stryker: Company Profile
TABLE 184: Zimmer Biomet: Company Profile
TABLE 185: Smith+Nephew: Company Profile
TABLE 186: Globus Medical: Company Profile
TABLE 187: Brainlab: Company Profile
TABLE 188: CMR Surgical: Company Profile
TABLE 189: Distalmotion: Company Profile
TABLE 190: Moon Surgical: Company Profile
TABLE 191: Vicarious Surgical: Company Profile
TABLE 192: Virtual Incision: Company Profile
TABLE 193: Noah Medical: Company Profile
TABLE 194: PROCEPT BioRobotics: Company Profile
TABLE 195: THINK Surgical: Company Profile
TABLE 196: Quantum Surgical: Company Profile
TABLE 197: Medical Microinstruments: Company Profile
TABLE 198: KARL STORZ / Asensus Surgical: Company Profile
TABLE 199: Activ Surgical: Company Profile
TABLE 200: Neocis: Company Profile
TABLE 201: Accuray: Company Profile
TABLE 202: Renishaw: Company Profile
TABLE 203: U.S. Autonomous Surgical Robotics Market: Future Market Scenario Analysis, 2026–2035
TABLE 204: U.S. Autonomous Surgical Robotics Market: Surgical Autonomy Evolution, 2026–2035
TABLE 205: U.S. Autonomous Surgical Robotics Market: Disruptive Technologies Impact Matrix
TABLE 206: U.S. Autonomous Surgical Robotics Market: Surgical Computer Vision and AI Opportunity Matrix
TABLE 207: U.S. Autonomous Surgical Robotics Market: Software-Defined Robotics Business Model Outlook
TABLE 208: U.S. Autonomous Surgical Robotics Market: ASC Expansion Opportunity
TABLE 209: U.S. Autonomous Surgical Robotics Market: Business Opportunities for Startups and Existing Players
TABLE 210: U.S. Autonomous Surgical Robotics Market: Investment Prioritization Matrix
TABLE 211: U.S. Autonomous Surgical Robotics Market: High-Potential Technology-Application Matrix
TABLE 212: U.S. Autonomous Surgical Robotics Market: Autonomous Surgery Commercialization Roadmap, 2026–2035
TABLE 213: U.S. Autonomous Surgical Robotics Market: Strategic Recommendations for Surgical Robotics Manufacturers
TABLE 214: U.S. Autonomous Surgical Robotics Market: Strategic Recommendations for AI and Surgical Software Developers
TABLE 215: U.S. Autonomous Surgical Robotics Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 216: U.S. Autonomous Surgical Robotics Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 217: U.S. Autonomous Surgical Robotics Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 218: U.S. Autonomous Surgical Robotics Market: Strategic Recommendations for New Entrants and Startups
TABLE 219: U.S. Autonomous Surgical Robotics Market: Go-to-Market Strategy Considerations
TABLE 220: U.S. Autonomous Surgical Robotics Market: FDA and Clinical Evidence Strategy
TABLE 221: U.S. Autonomous Surgical Robotics Market: State and Regional Market Prioritization
TABLE 222: U.S. Autonomous Surgical Robotics Market: Pricing, Recurring Revenue and Portfolio Expansion Guidance
TABLE 223: U.S. Autonomous Surgical Robotics Market: Scope Limitation
TABLE 224: U.S. Autonomous Surgical Robotics Market: Autonomous Surgical Robotics Definition Limitation
TABLE 225: U.S. Autonomous Surgical Robotics Market: Market Revenue Attribution Limitation
TABLE 226: U.S. Autonomous Surgical Robotics Market: Data Use Limitation
TABLE 227: U.S. Autonomous Surgical Robotics Market: Forecasting Limitation
TABLE 228: U.S. Autonomous Surgical Robotics Market: Emerging Technology and Clinical Development Limitation
TABLE 229: U.S. Autonomous Surgical Robotics Market: Regulatory Status Limitation
TABLE 230: U.S. Autonomous Surgical Robotics Market: Legal Disclaimer
TABLE 231: U.S. Autonomous Surgical Robotics Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Autonomous Surgical Robotics Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Autonomous Surgical Robotics Market Boundary and Autonomy Spectrum
FIGURE 4: U.S. Autonomous Surgical Robotics Market Ecosystem
FIGURE 5: Stakeholder Analysis Framework
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: U.S. Autonomous Surgical Robotics Market Dynamics
FIGURE 8: Innovation & Patent Landscape, 2021–2025
FIGURE 9: Surgical Procedure Automation Opportunity Framework
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Autonomous Surgical Robotics Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Autonomous Surgical Robotics Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Autonomous Surgical Robotics Market Year-wise Growth Curve, 2021–2035
FIGURE 15: PESTEL Analysis
FIGURE 16: Porter’s Five Forces Analysis
FIGURE 17: Value Chain Analysis
FIGURE 18: Supply Chain Analysis
FIGURE 19: AI, Computer Vision and Surgical Data Ecosystem
FIGURE 20: FDA Regulatory Pathway Framework for Autonomous Surgical Robotics
FIGURE 21: Hospital and ASC Robotic Surgery Economics Framework
FIGURE 22: System Type Segment Market Share Analysis, 2025 & 2035
FIGURE 23: System Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Soft-Tissue Robotic Surgical Platforms Market Forecast, 2021–2035
FIGURE 25: Orthopedic Robotic Surgical Systems Market Forecast, 2021–2035
FIGURE 26: Spine and Neurosurgical Robotic Systems Market Forecast, 2021–2035
FIGURE 27: Endoluminal and Image-Guided Interventional Robotic Systems Market Forecast, 2021–2035
FIGURE 28: Microsurgery and Specialty Robotic Systems Market Forecast, 2021–2035
FIGURE 29: Level of Autonomy Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Level of Autonomy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 31: Intelligent Assistance and Low-Level Autonomy Growth Trend
FIGURE 32: Task-Level and Conditional Autonomy Growth Trend
FIGURE 33: Supervised High Autonomy Growth Trend
FIGURE 34: Fully Autonomous Surgical Systems Commercialization Curve
FIGURE 35: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 36: Application Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Orthopedic Surgery Market Forecast and Trend Analysis, 2021–2035
FIGURE 38: General Surgery Market Forecast and Trend Analysis, 2021–2035
FIGURE 39: Urology Market Forecast and Trend Analysis, 2021–2035
FIGURE 40: Gynecologic Surgery Market Forecast and Trend Analysis, 2021–2035
FIGURE 41: Neurosurgery and Spine Surgery Market Forecast and Trend Analysis, 2021–2035
FIGURE 42: Thoracic, Microsurgery and Emerging Application Opportunity Map
FIGURE 43: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 44: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 45: Hospitals and Integrated Health Systems Market Forecast, 2021–2035
FIGURE 46: Academic and Teaching Medical Centers Market Forecast, 2021–2035
FIGURE 47: Ambulatory Surgery Centers Market Forecast, 2021–2035
FIGURE 48: Specialty Surgical Centers Market Forecast, 2021–2035
FIGURE 49: Autonomous Surgical Robotics Capital Acquisition Model Comparison
FIGURE 50: Robotic System Total Cost of Ownership Framework
FIGURE 51: Capital Payback and Utilization Threshold Framework
FIGURE 52: Robotic Procedure Throughput Economics
FIGURE 53: Software, AI and Recurring Revenue Opportunity
FIGURE 54: ASC Robotic Surgery Commercialization Framework
FIGURE 55: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 56: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: West Region U.S. Autonomous Surgical Robotics Market Share and Adoption Outlook, 2025
FIGURE 58: West Region Market Share Analysis by State, 2025
FIGURE 59: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 60: California Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 61: Washington Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 62: Arizona Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 63: Colorado Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 64: Oregon Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 65: Utah Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 66: Nevada Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 67: New Mexico Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 68: Idaho Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 69: Montana Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 70: Wyoming Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 71: Alaska Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 72: Hawaii Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 73: Northeast Region U.S. Autonomous Surgical Robotics Market Share and Adoption Outlook, 2025
FIGURE 74: Northeast Region Market Share Analysis by State, 2025
FIGURE 75: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 76: New York Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 77: Massachusetts Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 78: New Jersey Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 79: Pennsylvania Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 80: Connecticut Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 81: Maine Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 82: Vermont Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 83: New Hampshire Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 84: Rhode Island Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 85: Delaware Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 86: South Region U.S. Autonomous Surgical Robotics Market Share and Adoption Outlook, 2025
FIGURE 87: South Region Market Share Analysis by State, 2025
FIGURE 88: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 89: Texas Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 90: Florida Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 91: Georgia Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 92: North Carolina Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 93: Tennessee Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 94: South Carolina Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 95: Alabama Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 96: Mississippi Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 97: Louisiana Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 98: Arkansas Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 99: Kentucky Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 100: Oklahoma Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 101: Virginia Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 102: Maryland Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 103: West Virginia Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 104: Midwest Region U.S. Autonomous Surgical Robotics Market Share and Adoption Outlook, 2025
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 107: Illinois Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 108: Ohio Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 109: Michigan Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 110: Minnesota Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 111: Indiana Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 112: Wisconsin Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 113: Missouri Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 114: Iowa Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 115: Kansas Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 116: Nebraska Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 117: North Dakota Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 118: South Dakota Autonomous Surgical Robotics Market Forecast, 2021–2035
FIGURE 119: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 120: Company Positioning Matrix
FIGURE 121: Robotic Platform and Surgical Procedure Portfolio Benchmarking
FIGURE 122: Autonomous Capability and AI Benchmarking of Key Players
FIGURE 123: FDA-Cleared Indication Benchmarking
FIGURE 124: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 125: U.S. Autonomous Surgical Robotics Innovation Roadmap
FIGURE 126: Future Market Scenario Analysis, 2026–2035
FIGURE 127: Surgical Autonomy Evolution Roadmap, 2026–2035
FIGURE 128: Surgical Computer Vision and AI Opportunity Map
FIGURE 129: Autonomous Orthopedic Surgery Development Roadmap
FIGURE 130: Task-Level Soft-Tissue Automation Opportunity Map
FIGURE 131: Miniaturized and ASC Surgical Robotics Growth Roadmap
FIGURE 132: Disruptive Technologies Impact Matrix
FIGURE 133: Software-Defined Surgical Robotics Business Model Evolution
FIGURE 134: Investment Prioritization Matrix
FIGURE 135: High-Potential Technology-Application Matrix
FIGURE 136: Autonomous Surgery Commercialization Roadmap Through 2035
FIGURE 137: Strategic Growth Roadmap for U.S. Autonomous Surgical Robotics Companies
FIGURE 138: Go-to-Market Strategy Framework
FIGURE 139: FDA and Clinical Evidence Strategy Framework
FIGURE 140: Hospital Capital Procurement Strategy Framework
FIGURE 141: U.S. State and Regional Market Prioritization Framework
FIGURE 142: ASC Commercialization Strategy Framework
FIGURE 143: Pricing, Recurring Revenue and Portfolio Expansion Framework
FIGURE 144: Surgeon Training and Autonomous Robotics Adoption Framework
FIGURE 145: Report Scope, Market Boundary and Disclaimer Framework